Vitiligo causes patches of skin to lose their natural color, but the pattern of pigment loss varies from person to person.

Some people develop one small, isolated patch, while others notice multiple patches across different body areas. These differences help dermatologists classify the condition and plan appropriate care.

Focal vitiligo describes localized pigment loss that does not clearly fit an established pattern, while non-segmental vitiligo often affects several areas of the body, commonly on both sides.

However, an isolated patch may change over time, so its initial appearance does not always establish the final classification.

Understanding these differences can help you recognize common patterns, learn how dermatologists diagnose vitiligo, and explore available treatments. It can also help you prepare questions about monitoring your skin and whether clinical research may be an appropriate option.

What is focal vitiligo?

Focal vitiligo refers to a small, localized area of skin that has lost pigment without following the typical distribution of segmental vitiligo. It may appear on almost any part of the body, sometimes as a single patch without other visible areas of pigment loss.

Skin gets its color from melanin, a pigment produced by cells called melanocytes. In vitiligo, these cells are lost or stop functioning in affected areas, leaving the skin lighter than the surrounding skin.

Focal vitiligo is generally considered an unclassified or undetermined pattern because its future course may not be clear initially.

Common characteristics

• Limited distribution: One or a few localized patches.

• Visible color change: Affected skin may appear lighter or completely white.

• Uncertain progression: The patch may remain localized or additional patches may develop.

• No clear segmental pattern: The affected area does not follow a typical one-sided distribution.

A small patch does not automatically indicate focal vitiligo. Other skin conditions can also cause lighter areas, so a dermatologist should assess the skin before confirming the diagnosis.

What is non-segmental vitiligo?

Non-segmental vitiligo (NSV) is a form of vitiligo that commonly affects multiple body areas. Patches often appear on corresponding areas on both sides of the body, although the distribution is not always symmetrical.

This form is associated with autoimmune activity, in which the immune system mistakenly targets melanocytes. Researchers believe genetic susceptibility and other biological factors may also contribute, but the exact causes remain incompletely understood.

Non-segmental vitiligo can affect the face, hands, arms, legs, trunk, and areas around body openings. New patches may appear over time, while existing patches may expand or remain stable.

Common patterns of non-segmental vitiligo

• Generalized: Multiple patches across different body regions, often on both sides.

• Acrofacial: Pigment loss mainly affects the face and extremities, including the hands and feet.

• Universal: Extensive depigmentation affects nearly all the skin.

• Localized: Pigment loss remains limited to a few areas, even though the overall classification may be non-segmental.

These patterns describe where pigment loss occurs. They do not reliably predict how quickly vitiligo will progress or how well it will respond to treatment.

Focal vs. non-segmental vitiligo: Key differences

The main distinction involves the distribution of pigment loss and whether the condition fits a recognized clinical pattern.

Focal vitiligo is not necessarily a permanent, separate form of the condition. An initially isolated patch may later be classified as non-segmental or, in some cases, segmental vitiligo.

How does focal vitiligo differ from segmental vitiligo?

The terms focal and segmental can be confusing because both may involve limited areas of skin.

Segmental vitiligo typically affects one side or a particular segment of the body. It often develops relatively quickly over weeks or months and then stabilizes. Focal vitiligo, in contrast, describes an isolated patch without a clear segmental distribution.

The distinction matters because the pattern and progression can influence treatment decisions. Follow-up examinations may help a dermatologist determine which classification best describes the condition.

What causes these forms of vitiligo?

Both patterns involve the loss of pigment-producing cells, but the reasons pigment loss develops in particular locations are not fully understood.

Potential contributing factors include:

• Autoimmune activity: The immune system may attack melanocytes, particularly in non-segmental vitiligo.

• Genetic susceptibility: Inherited factors may increase the likelihood of developing the condition.

• Skin injury or irritation: New patches sometimes appear at sites of cuts, burns, friction, or other trauma. This is called the Koebner phenomenon.

• Other biological processes: Researchers are investigating oxidative stress and interactions between skin cells and the immune system.

Having a family history of vitiligo does not mean someone will necessarily develop it. Vitiligo is also not contagious and cannot spread through physical contact or sharing personal items.

How is vitiligo diagnosed?

A dermatologist typically diagnoses vitiligo by examining the skin, reviewing medical history, and assessing how the patches have changed over time.

Other conditions, including certain fungal infections and post-inflammatory hypopigmentation, can cause lighter areas of skin. The appearance of a patch alone may not establish its cause.

What to expect during an examination

• Skin examination: The dermatologist assesses the patches' color, borders, location, and distribution and checks for other affected areas.

• Medical history: You may be asked when the patches appeared, whether they have grown, and whether new patches or white hairs have developed.

• Wood's lamp examination: This ultraviolet light examination can make areas of pigment loss more visible, particularly when patches are difficult to distinguish under ordinary lighting.

• Additional testing: Blood tests are not necessary for everyone. A clinician may recommend thyroid testing or other investigations when symptoms or medical history suggest an associated condition. A skin biopsy is rarely needed when the appearance is typical.

For an isolated patch, follow-up can be particularly useful because changes in distribution may clarify the diagnosis.

What treatments are available?

Treatment depends on the affected body areas, extent of pigment loss, disease activity, and personal preferences. The goals may include restoring pigment, limiting further changes, or reducing the visible contrast between affected and unaffected skin.

Topical treatments

Prescription treatments include topical corticosteroids and calcineurin inhibitors, such as tacrolimus. Ruxolitinib cream is another option for eligible patients with non-segmental vitiligo. Suitability depends on factors such as age, affected skin area, and current prescribing guidance.

These treatments require appropriate medical guidance because effectiveness and potential side effects vary.

Phototherapy

Narrowband ultraviolet B (NB-UVB) phototherapy uses controlled ultraviolet light to stimulate repigmentation. It may be considered when vitiligo affects multiple areas or continues to progress.

Treatment usually requires repeated sessions. Results vary by person and body site, with the hands and feet often responding less readily than some other areas.

Surgical treatments

Selected people with stable vitiligo may be candidates for procedures that transfer pigment-producing cells or skin tissue into affected areas. These procedures are generally unsuitable when new patches continue to appear.

Cosmetic approaches

Skin camouflage products and self-tanners can help reduce the visible contrast between affected and unaffected areas. Broad-spectrum sunscreen is important because depigmented skin is more susceptible to sunburn.

No treatment guarantees complete or permanent repigmentation. A dermatologist can explain the likely benefits, limitations, and risks of each option.

Can you participate in vitiligo clinical research?

Clinical research helps investigators evaluate potential treatments and improve understanding of vitiligo. Depending on the study, participants may receive an investigational treatment, an approved treatment, or a placebo, along with scheduled examinations and safety monitoring.

Indiana University School of Medicine offers opportunities to participate in dermatology clinical research. Study availability, enrollment status, and eligibility requirements may change, so interested individuals should contact the research team for the latest information.

Conclusion

Focal and non-segmental vitiligo differ mainly in their patterns of pigment loss. Focal vitiligo describes a small, isolated patch whose classification may initially be uncertain, while non-segmental vitiligo often affects multiple areas, commonly on both sides of the body.

A dermatologist can distinguish vitiligo from other causes of skin discoloration, monitor changes, and discuss suitable treatments. If you are interested in research, you can explore opportunities to join vitiligo clinical trials in Indiana through Indiana University School of Medicine's dermatology research program. Contact the study team to confirm current enrollment and eligibility before deciding whether to participate.